Oscillating positive expiratory pressure device

RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 13/674,340, filed on Nov. 12, 2012, pending, which is a continuation of U.S. application Ser. No. 12/607,496, filed on Oct. 28, 2009, now U.S. Pat. No. 8,327,849, which claims the benefit of U.S. Provisional Application No. 61/109,075, filed on Oct. 28, 2008, all of which are incorporated herein by reference.

TECHNICAL FIELD

The present disclosure relates to an expiratory treatment device, and in particular, to an oscillating positive expiratory pressure (“OPEP”) device.

BACKGROUND

Each day, humans may produce upwards of 30 milliliters of sputum, which is a type of bronchial secretion. Normally, an effective cough is sufficient to loosen secretions and clear them from the body's airways. However, for individuals suffering from more significant bronchial obstructions, such as collapsed airways, a single cough may be insufficient to clear the obstructions.

OPEP therapy represents an effective bronchial hygiene technique for the removal of bronchial secretions in the human body and is an important aspect in the treatment and continuing care of patients with bronchial obstructions, such as those suffering from chronic obstructive lung disease. It is believed that OPEP therapy, or the oscillation of exhalation pressure at the mouth during exhalation, effectively transmits an oscillating back pressure to the lungs, thereby splitting open obstructed airways and loosening the secretions contributing to bronchial obstructions.

OPEP therapy is an attractive form of treatment because it can be easily taught to most hospitalized patients, and such patients can assume responsibility for the administration of OPEP therapy throughout their hospitalization and also once they have returned home. To that end, a number of portable OPEP devices have been developed.

BRIEF SUMMARY

A portable OPEP device and a method of performing OPEP therapy is described herein. In one aspect, a portable OPEP device includes a housing defining a chamber, a chamber inlet configured to receive exhaled air into the chamber, a chamber outlet configured to permit exhaled air to exit the chamber, a deformable restrictor member positioned in an exhalation flow path between the chamber inlet and the chamber outlet, and an oscillation member disposed within the chamber. The deformable restrictor member and the oscillation member are moveable relative to one another between an engaged position, where the oscillation member is in contact with the deformable restrictor member and a disengaged position, where the oscillation member is not in contact with the deformable restrictor member. The deformable restrictor member and the oscillation member are also configured to move from the engaged position to the disengaged position in response to a first exhalation pressure at the chamber inlet, and move from the disengaged position to an engaged position in response to a second exhalation pressure at the chamber inlet. The first exhalation pressure is greater than the second exhalation pressure.

In another aspect, the deformable restrictor member deforms in response to an intermediate exhalation pressure at the chamber inlet, and returns to a natural shape in response to the first exhalation pressure at the chamber inlet.

In another aspect, the OPEP device has a biasing member positioned to bias the deformable restrictor member and the oscillation member to the engaged position. The biasing member maybe a spring. Alternatively, the biasing member may have at least one pair of magnets, wherein a first magnet of the at least one pair of magnets is connected to the oscillation member and a second magnet of the at least one pair of magnets is connected to the housing. The position of the biasing member may also be selectively moveable to adjust the amount of bias

In yet another aspect, the OPEP device includes a glide surface extending from the housing into the chamber, such that the glide surface is in sliding contact about the oscillation member, and movement of the oscillation member is substantially limited to reciprocal movement about an axis of the oscillation member.

In another aspect, the oscillation member includes at least one channel adapted so that the exhalation flow path is not completely restricted when the deformable restrictor member and the oscillation member are in the engaged positioned.

In another aspect, the OPEP device includes a mouthpiece connected to the housing that is in fluid communication with the chamber inlet. The mouthpiece may have a cross-sectional area greater than a cross-sectional area of the chamber inlet.

In yet another aspect, the housing has a first portion and a second portion, with the second portion being removably connected to the first portion.

In another aspect, the OPEP device includes a respiratory portal for receiving an aerosol medicament. Additionally, the oscillation member may comprise a one-way valve configured to permit the aerosol medicament to enter the chamber through the respiratory portal, the respiratory portal being in fluid communication with the chamber inlet when the one-way valve is open.

In another aspect, a method of performing oscillating positive expiratory pressure therapy is provided. The method includes passing a flow of exhaled air along an exhalation flow path defined between an inlet and an outlet of a chamber in an oscillating positive expiratory pressure device. The method also includes restricting the flow of exhaled air by maintaining a deformable restrictor member and an oscillation member disposed within the chamber in an engaged position, where the oscillation member is in contact with the deformable restrictor member, until a first exhalation pressure is reached at a chamber inlet. The method further includes unrestricting the flow of exhaled air by moving the deformable restrictor member and the oscillation member to a disengaged position, where the oscillation member is not in contact with the deformable restrictor member, until a second exhalation pressure is reached at the chamber inlet. The method also includes returning the deformable restrictor member and the oscillation member to the engaged position with a biasing force when the second exhalation pressure is reached at the chamber inlet. The first exhalation pressure may be greater than the second exhalation pressure. Finally, the method may also include deforming the deformable restrictor member in response to an intermediate exhalation pressure at the chamber inlet, and returning the deformable restrictor member to a natural shape in response to the first exhalation pressure at the chamber inlet.

In another embodiment, a system for providing oscillating positive expiratory pressure therapy in combination with aerosol therapy is provided. The system includes an oscillating positive expiratory pressure apparatus having a housing defining a chamber, a chamber inlet configured to receive exhaled air into the chamber, and a chamber outlet configured to permit exhaled air to exit the chamber. The oscillating positive expiratory pressure apparatus also has an exhalation flow path defined between the chamber inlet and the chamber outlet, and an oscillation member disposed within the chamber and configured to operatively restrict a flow of exhaled air along the exhalation flow path. The oscillation member is moveable relative to the flow path between a restrictive position, where the flow of exhaled air is substantially restricted and an unrestrictive position, where the flow of exhaled air is substantially unrestricted. The oscillating positive expiratory pressure apparatus may also have a respiratory portal for receiving an aerosol medicament. The respiratory portal maybe in fluid communication with the chamber inlet. The system also includes an aerosol therapy apparatus removably connected to the respiratory portal of the oscillating positive expiratory pressure apparatus. The aerosol therapy apparatus includes an aerosol housing having an aerosol chamber for holding an aerosol medicament, and an aerosol outlet communicating with the aerosol chamber for permitting the aerosol medicament to be withdrawn from the aerosol chamber.

BRIEF DESCRIPTION OF THE DRAWINGS

<figref idref="DRAWINGS">FIG. 1</figref> is a front perspective view of a first embodiment of an OPEP device;

<figref idref="DRAWINGS">FIG. 2</figref> is a side perspective view of the embodiment of <figref idref="DRAWINGS">FIG. 1</figref>;

<figref idref="DRAWINGS">FIG. 3</figref> is a cross-sectional side view of the embodiment of <figref idref="DRAWINGS">FIG. 1</figref>, showing a deformable restrictor member and an oscillation member in an engaged position;

<figref idref="DRAWINGS">FIG. 4</figref> is a cross-sectional perspective view of an inlet insert shown in the embodiment of <figref idref="DRAWINGS">FIG. 1</figref>;

<figref idref="DRAWINGS">FIG. 5</figref> is a cross-sectional perspective view of a deformable restrictor member shown in the embodiment of <figref idref="DRAWINGS">FIG. 1</figref>;

<figref idref="DRAWINGS">FIG. 6</figref> is a front perspective view of an oscillation member shown in the embodiment of <figref idref="DRAWINGS">FIG. 3</figref>;

<figref idref="DRAWINGS">FIG. 7</figref> is a rear perspective view of the oscillation member shown in the embodiment of <figref idref="DRAWINGS">FIG. 3</figref>;

<figref idref="DRAWINGS">FIG. 8</figref> is a cross-sectional side view of a second embodiment of an OPEP device, showing a deformable restrictor member and an oscillation member in an engaged position;

<figref idref="DRAWINGS">FIG. 9</figref> is a cross-sectional side view of the embodiment of <figref idref="DRAWINGS">FIG. 8</figref>, showing the flow of air upon a user's inhalation;

<figref idref="DRAWINGS">FIG. 10</figref> is a cross-sectional side view of the embodiment of <figref idref="DRAWINGS">FIG. 8</figref>, showing the flow of air upon a user's exhalation;

<figref idref="DRAWINGS">FIG. 11</figref> is a cross-sectional side view of an OPEP device connected to a nebulizer, showing the flow of an aerosol medicament upon a user's inhalation;

<figref idref="DRAWINGS">FIG. 12</figref> is a cross-sectional side view of the OPEP device and nebulizer of <figref idref="DRAWINGS">FIG. 11</figref>, showing the flow of air upon a user's exhalation; and,

<figref idref="DRAWINGS">FIG. 13</figref> is a cross-sectional rear perspective view of a third embodiment of an OPEP device having a biasing member comprised of at least one pair of opposing magnets.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

OPEP therapy is very effective within a specific range of operating conditions. For example, an adult human may have an exhalation flow rate ranging from 10 to 60 liters per minute, and may maintain a static exhalation pressure in the range of 10 to 20 cm H₂O. Within these parameters, OPEP therapy is believed to be most effective when changes in the exhalation pressure range from 5 to 20 cm H₂O oscillating at a frequency of 10 to 40 Hz. In contrast, an infant may have a much lower exhalation flow rate, and may maintain a lower static exhalation pressure, thereby altering the operating conditions most effective for OPEP therapy. As described below, the present invention is configurable so that ideal operating conditions may be selected and maintained.

Referring to <figref idref="DRAWINGS">FIG. 1</figref>, a first embodiment of an assembled OPEP device <b>100</b> is shown. The OPEP device <b>100</b> comprises a housing <b>102</b> having a front portion <b>104</b> and a rear portion <b>106</b> which together defines a chamber <b>108</b> (see <figref idref="DRAWINGS">FIG. 3</figref>). The housing <b>102</b> may be constructed of any durable material, such as a plastic or a metal. The OPEP device <b>100</b> shown in <figref idref="DRAWINGS">FIG. 1</figref> is substantially spherical in shape, which provides for an easy grasp of the OPEP device <b>100</b> in the hands of a user, as well as portability. It should be appreciated, however, that the OPEP device <b>100</b> could be any shape, so long as it defines a chamber <b>108</b> capable of housing the necessary components, as described herein. Preferably, the housing <b>102</b> is openable so the chamber <b>108</b> may be accessed for cleaning and replacing components contained therein. As shown, the front portion <b>104</b> and the rear portion <b>106</b> of the housing <b>102</b> are removably connected along a joint <b>110</b>, such as by a snap fit or a threaded screw connection.

The OPEP device <b>100</b> also includes a mouthpiece <b>112</b> which may either be formed as an integral part of the housing <b>102</b> or removably attached to the housing <b>102</b>. Although the mouthpiece <b>112</b> is shown as being cylindrical in shape, the mouthpiece <b>112</b> could be any number of alternative sizes or shapes to accommodate various users of the OPEP device <b>100</b>, such as children or adults. A chamber inlet <b>114</b> positioned within the mouthpiece <b>112</b> is configured to receive exhaled air into the chamber <b>108</b>. In view of the description below, it should be apparent that the cross sectional area of the chamber inlet <b>114</b> is an important variable affecting the exhalation pressure generated at the mouth of a user, and maybe modified or selectively replaced according to the desired operating conditions.

A side perspective view of the OPEP device <b>100</b> is shown in <figref idref="DRAWINGS">FIG. 2</figref>. The OPEP device <b>100</b> further comprises at least one chamber outlet <b>116</b> configured to permit exhaled air to exit the chamber <b>108</b>. The at least one chamber outlet <b>116</b> may comprise any number of apertures, having any shape or size. Furthermore, the at least one chamber outlet <b>116</b> maybe located elsewhere on the housing <b>102</b>. The OPEP device <b>100</b> may also include a grate <b>117</b> to prevent unwanted objects from entering housing <b>102</b>.

Referring to <figref idref="DRAWINGS">FIG. 3</figref>, a cross-sectional side view of the OPEP device <b>100</b> shows the internal components of the OPEP device <b>100</b>. The minimal number of components contained in the OPEP device <b>100</b>, and its relatively simple operation, make the OPEP device <b>100</b> particularly suitable for single patient use. In general, the housing <b>102</b> of the OPEP device <b>100</b> encloses an inlet insert <b>118</b>, a deformable restrictor member <b>120</b>, an oscillation member <b>122</b>, a coil spring <b>124</b>, and a glide surface <b>126</b>. As explained below, the various alternatives for each of the inlet insert <b>118</b>, the deformable restrictor member <b>120</b>, the oscillation member <b>122</b>, and the coil spring <b>124</b> provide of a highly configurable OPEP device <b>100</b>.

A cross-sectional perspective view of the inlet insert <b>118</b> is shown in <figref idref="DRAWINGS">FIG. 4</figref>. The inlet insert <b>118</b> is removably connectable to the housing <b>102</b> and/or mouthpiece <b>112</b> of the OPEP device <b>100</b>, and includes the chamber inlet <b>114</b>. The chamber inlet <b>114</b> may be a single narrow aperture, or alternatively, may comprise any number of apertures having any size or shape. Because the inlet insert <b>118</b> is removably connectable to the OPEP device <b>100</b>, a user may select an inlet insert <b>118</b> having the appropriate sized chamber inlet <b>114</b> for the prescribed OPEP therapy. It is important, however, that the mouthpiece <b>112</b> have a cross-sectional area greater than the cross-sectional area of the chamber inlet <b>114</b>.

The inlet insert <b>118</b> is configured to be snap or compression fit within the front portion <b>104</b> of the housing <b>102</b>, which maybe accomplished while the front portion <b>104</b> and the rear portion <b>106</b> are detached. The inlet insert <b>118</b> includes an annular recess <b>128</b> for receiving a corresponding annular protrusion <b>130</b>, which may be located on a rim <b>131</b> connected to either the mouthpiece <b>112</b> or the housing <b>102</b>, as shown in <figref idref="DRAWINGS">FIG. 4</figref>. Furthermore, the inlet insert <b>118</b> is shaped to fit within the spherically shaped OPEP device <b>100</b>; however, the inlet insert <b>118</b> could be modified to fit within any other shaped OPEP device. Alternatively, the inlet insert <b>118</b> and the chamber inlet <b>114</b> may be formed as an integral part of the housing <b>102</b> or the mouthpiece <b>112</b>. The inlet insert <b>118</b> further includes an annular mounting surface <b>132</b> for supporting the deformable restrictor member <b>120</b>, as described below.

Referring to <figref idref="DRAWINGS">FIG. 5</figref>, a cross-sectional perspective view of the deformable restrictor member <b>120</b> is shown. The deformable restrictor member <b>120</b> operates as a regulator of the exhalation pressure at the chamber inlet <b>114</b>. The deformable restrictor member <b>120</b> maybe constructed of an elastic material, preferably having an elasticity of at least 40 durometers (A scale). Like the inlet insert <b>118</b>, the deformable restrictor member <b>120</b> maybe any number of shapes, but is shown in <figref idref="DRAWINGS">FIG. 5</figref> as being circular to fit within the spherically shaped OPEP device <b>100</b>.

The deformable restrictor member <b>120</b> generally includes an upper portion <b>134</b>, a lower portion <b>136</b>, and a reinforcing band <b>138</b> of elastic material. As shown in <figref idref="DRAWINGS">FIG. 3</figref>, the upper portion <b>134</b> is configured for mounting the deformable restrictor member <b>120</b> on the mounting surface <b>132</b> and about the rim <b>131</b>, as explained above. When the front portion <b>104</b> and the rear portion <b>106</b> of the housing <b>102</b> are detached, the upper portion <b>134</b> of the deformable restrictor member <b>120</b> is mountable about the rim <b>131</b> of the inlet insert <b>118</b>, and the inlet insert <b>118</b> maybe snapped into place within the housing <b>102</b>. Once the inlet insert <b>118</b> is connected to the housing <b>102</b>, the deformable restrictor member <b>120</b> is retained by the rim <b>131</b>, the mounting surface <b>132</b>, and the front portion <b>104</b> of the housing <b>102</b>. Alternatively, the housing <b>102</b> or the mouthpiece <b>112</b> may be configured to provide the rim <b>131</b> and the mounting surface <b>132</b> for mounting and retaining the deformable restrictor member <b>120</b>.

The deformable restrictor member <b>120</b>, and in particular, the lower portion <b>136</b>, is configured to deform as the exhalation pressure at the chamber inlet <b>114</b> increases. Preferably, the lower portion <b>136</b> of the deformable restrictor member <b>120</b> should be curved inward so that, as the deformable restrictor member <b>120</b> deforms, the lower portion <b>136</b> expands in a direction away from the upper portion <b>134</b>. To improve the elasticity and rigidness of the deformable restrictor member <b>120</b>, a reinforcing band <b>138</b> of elastic material maybe added to the deformable restrictor member <b>120</b>. Depending on the shape of the deformable restrictor member <b>120</b> and the desired elasticity, the reinforcing band <b>138</b> maybe omitted or located elsewhere on the deformable restrictor member <b>120</b>.

Referring to <figref idref="DRAWINGS">FIG. 6</figref>, a front perspective view of an oscillation member <b>122</b> is shown. In general, the oscillation member <b>122</b> includes a contact surface <b>140</b> connected to the end of a post <b>142</b>. The contact surface <b>140</b> is configured to engage the lower portion <b>136</b> of the deformable restrictor member <b>120</b>. As shown in <figref idref="DRAWINGS">FIGS. 3 and 6</figref>, the contact surface <b>140</b> maybe hemispherically shaped to fit within a correspondingly shaped portion of the inlet insert <b>118</b>, or a correspondingly shaped portion of the housing <b>102</b> or mouthpiece <b>112</b> if the inlet insert <b>118</b> is omitted. Alternatively, the contact surface <b>140</b> maybe substantially flat.

The contact surface <b>140</b> shown in <figref idref="DRAWINGS">FIG. 6</figref> includes at least one channel <b>143</b> which traverses a portion of the contact surface <b>140</b> where the deformable restrictor member <b>120</b> and the oscillation member <b>122</b> engage one another. In this embodiment, the channels <b>143</b> are sized such that an air passage from the chamber inlet <b>114</b> to the chamber outlet <b>116</b> is maintained during both inhalation and exhalation via the space defined by the restrictor member <b>120</b> and the channels <b>143</b>. This air passage, or collection of air passages, is sized to prevent complete restriction of air flow but selected to allow sufficient build-up of pressure to provide oscillating pressure upon patient exhalation.

Although the contact surface <b>140</b> is shown in <figref idref="DRAWINGS">FIG. 6</figref> as having seven separate channels <b>143</b>, the contact surface <b>140</b> could include any number of channels <b>143</b>. Furthermore, the one or more channels <b>143</b> may have a variety of sizes, depending upon the desired restriction of exhaled air received from the user. Alternatively, the contact surface <b>140</b> may be fabricated without any channels <b>143</b>. Because the oscillation member <b>122</b> is removably enclosed within the housing <b>102</b> of the OPEP device <b>100</b>, a user may select an oscillation member <b>122</b> having the appropriate shape, size, or number of channels for the prescribed OPEP therapy.

A rear perspective view of the oscillation member <b>122</b> is shown in <figref idref="DRAWINGS">FIG. 7</figref>. The post <b>142</b> is configured for positioning about the glide surface <b>126</b>, as shown in <figref idref="DRAWINGS">FIG. 3</figref>, so that the post <b>142</b> is in sliding contact with the glide surface <b>126</b>. When the post <b>142</b> is positioned about the glide surface <b>126</b>, the oscillation member <b>122</b> is substantially limited to reciprocal movement about the central axis of the oscillation member <b>122</b>. As shown in <figref idref="DRAWINGS">FIGS. 3 and 7</figref>, the glide surface <b>126</b> and the post <b>142</b> are shaped as hollow cylinders, and the post <b>142</b> is sized to fit within the glide surface <b>126</b>. However, the glide surface <b>126</b> and the post <b>142</b> may have any shape, and the glide surface <b>126</b> maybe alternatively sized to fit within the post <b>142</b>. The oscillation member <b>122</b> also includes a skirt <b>144</b> for aligning a biasing member, such as the coil spring <b>124</b>, about the oscillation member <b>122</b> when the OPEP device <b>100</b> is assembled.

Referring to <figref idref="DRAWINGS">FIG. 3</figref>, the coil spring <b>124</b> is positioned to extend from the housing <b>102</b> and contact a lower surface <b>146</b> of the oscillation member <b>122</b>. The coil spring <b>124</b> is positioned to bias the oscillation member <b>122</b> into engagement with the deformable restrictor member <b>120</b>. Similar to the deformable restrictor member <b>120</b> and the oscillation member <b>122</b>, the coil spring <b>124</b> maybe selectively replaced with other springs have a different rigidity or number of coils to achieve the desired operating conditions for the prescribed OPEP treatment.

To administer OPEP therapy using the OPEP device <b>100</b> descried above, a user begins by exhaling into the mouthpiece <b>112</b>. In doing so, an exhalation flow path <b>148</b> is defined between the chamber inlet <b>114</b> and the at least one chamber outlet <b>116</b>. The exhalation pressure at the chamber inlet <b>114</b> represents a function of the flow of exhaled air permitted to traverse the exhalation flow path <b>148</b> and exit the OPEP device <b>100</b> through the chamber outlet <b>116</b>. As the exhalation pressure at the chamber inlet <b>114</b> changes, an equal back pressure is effectively transmitted to the respiratory system of the user.

As shown in <figref idref="DRAWINGS">FIG. 3</figref>, prior to using the OPEP device <b>100</b>, the oscillation member <b>122</b> is biased to an engaged position, where the deformable restrictor member <b>120</b> is in contact with the oscillation member <b>122</b>. In the engaged position, the exhalation flow path <b>148</b> is substantially restricted by the deformable restrictor member <b>120</b> and the oscillation member <b>122</b>. As a user exhales into the OPEP device <b>100</b>, an initial exhalation pressure at the chamber inlet <b>114</b> begins to increase, as only a fraction of the exhaled air is permitted to flow along the exhalation flow path <b>148</b> through the at least one channel <b>143</b> on the oscillation member <b>122</b>. As the exhalation pressure increases at the chamber inlet <b>114</b> to an intermediate pressure, the deformable restrictor member <b>120</b> begins to expand under the force of the increased pressure. As the deformable restrictor member <b>120</b> expands, the lower portion <b>136</b> moves in an outward direction, toward the oscillation member <b>122</b>. In the engaged position, however, the outward movement of the lower portion <b>136</b> is resisted by the oscillation member <b>122</b>, which is biased against the deformable restrictor member <b>120</b> by the coil spring <b>124</b>. As the exhalation pressure continues to increase, the deformable restrictor member <b>120</b> continues to deform until a maximum point of expansion is obtained. When the deformable restrictor member <b>120</b> obtains its maximum expansion, the exhalation pressure is also at a maximum pressure.

At the maximum point of expansion, the increasing exhalation pressure causes the deformable restrictor member <b>120</b> to quickly retract, ultimately returning to its natural shape. As the deformable restrictor member <b>120</b> retracts, the deformable restrictor member <b>120</b> and the oscillation member <b>122</b> move to a disengaged position, where the deformable restrictor member <b>120</b> is not in contact with the oscillation member <b>122</b>. At that time, exhaled air is permitted to flow substantially unrestricted along the exhalation flow path <b>148</b> from the chamber inlet <b>114</b> to the chamber outlet <b>116</b>. Because the retraction of the deformable restrictor member <b>120</b> is quicker than the movement of the oscillation member <b>122</b> under the biasing force of the coil spring <b>124</b>, the deformable restrictor member <b>120</b> and the oscillation member <b>122</b> remain in the disengaged position for a short period of time, during which the exhalation pressure at the chamber inlet <b>114</b> decreases. Depending on multiple variables, including the elasticity of the deformable restrictor member <b>120</b>, the biasing force of the coil spring <b>124</b>, and the exhalation flow rate, the deformable restrictor member <b>120</b> and the oscillation member <b>122</b> may remain in the disengaged position for only a fraction of a second.

After the deformable restrictor member <b>120</b> returns to its natural shape, the oscillation member <b>122</b>, under the biasing force of the coil spring <b>124</b>, moves back into an engaged position with the deformable restrictor member <b>120</b>. Then, as a user continues to exhale, the exhalation pressure at the chamber inlet <b>114</b> begins to increase, and the cycle described above is repeated. In this way, the exhalation pressure at the chamber inlet <b>114</b> oscillates between a minimum and a maximum so long as a user continues to exhale into the OPEP device <b>100</b>. This oscillating pressure is effectively transmitted back to the respiratory system of the user to provide OPEP therapy.

A cross-sectional side view of a second embodiment of an OPEP device <b>200</b> is shown in <figref idref="DRAWINGS">FIG. 8</figref>. Like the OPEP device <b>100</b>, a housing <b>202</b> of the OPEP device <b>200</b> encloses a deformable restrictor member <b>220</b>, an oscillation member <b>222</b>, a coil spring <b>224</b>, and a glide surface <b>226</b>. The OPEP device <b>200</b> also includes a mouthpiece <b>212</b>, a chamber inlet <b>214</b>, a chamber outlet <b>216</b>, and has an exhalation flow path <b>248</b> defined therebetween.

The OPEP device <b>200</b> further comprises an adjustment plate <b>254</b> for selectively moving an end of a biasing member, such as the coil spring <b>224</b>, to adjust the amount of bias. The adjustment plate <b>254</b> is connected to at least one thumb screw <b>256</b> extending from the adjustment plate <b>254</b> to a location outside the housing <b>202</b>. In this way, a user may rotate the at least one thumb screw <b>256</b> in one direction to move both the adjustment plate <b>254</b> and an end of the coil spring <b>224</b> toward the oscillation member <b>222</b>, thereby increasing the bias. A user may rotate the at least one thumb screw <b>256</b> the opposite direction to decrease the bias. By changing the amount of bias, a user may selectively increase or decrease the resistance the oscillation member <b>222</b> applies against the deformable restrictor member <b>220</b> while in the engaged position. A change in the bias also changes the rate at which the oscillation member <b>222</b> moves from the engaged position to the disengaged position, and back to the engaged position, during the administration of OPEP therapy.

The OPEP device <b>200</b> shown in <figref idref="DRAWINGS">FIG. 8</figref> further comprises a respiratory portal <b>250</b> and a one-way valve <b>252</b> positioned on the oscillation member <b>222</b>. The oscillation member <b>222</b> shown in <figref idref="DRAWINGS">FIG. 8</figref> omits the at least one channel and has a substantially flat contact surface <b>240</b> to accommodate the one-way valve <b>252</b>. The one-way valve <b>252</b> is configured to open as a user inhales, and permit air to enter the chamber <b>208</b> from the respiratory portal <b>250</b>, as shown in <figref idref="DRAWINGS">FIG. 9</figref>. In contrast, the one-way valve <b>252</b> is closed during exhalation, as seen at one point during the administration of OPEP therapy in <figref idref="DRAWINGS">FIG. 10</figref>, when the deformable restrictor member <b>220</b> and the oscillation member <b>222</b> are in the disengaged position.

Referring to <figref idref="DRAWINGS">FIG. 11</figref>, the respiratory portal <b>250</b> of the OPEP device <b>200</b> is also configured to receive an aerosol outlet <b>260</b> of a nebulizer <b>258</b>. The nebulizer <b>258</b> maybe removably connected to the OPEP device <b>200</b> by any suitable means for the combined administration of OPEP and aerosol therapies. Any of a number of commercially available nebulizers may be used with the OPEP device <b>200</b>. One suitable nebulizer is the AeroEclipse® II breath actuated nebulizer available from Trudell Medical International of London, Canada. Descriptions of suitable nebulizers may be found in U.S. Pat. No. 5,823,179, the entirety of which is hereby incorporated by reference herein.

In this configuration, a user receives aerosol therapy upon inhalation. As seen in <figref idref="DRAWINGS">FIG. 11</figref>, when a user inhales, the one-way valve <b>252</b> opens, and an aerosol medicament is drawn from the aerosol output <b>260</b>, through the respiratory portal <b>250</b> and the chamber <b>208</b>, and into the respiratory system of the user. In contrast, OPEP therapy is delivered upon exhalation. As seen in <figref idref="DRAWINGS">FIG. 12</figref>, when a user exhales, the one-way valve <b>252</b> closes, the aerosol medicament is contained within the respiratory portal <b>250</b>, and the OPEP device <b>200</b> is able to deliver OPEP therapy in accordance with the method described above.

A cross-sectional perspective view of a third embodiment of an OPEP device <b>300</b> is shown in <figref idref="DRAWINGS">FIG. 13</figref>. In general, a housing <b>302</b> of the OPEP device <b>300</b> encloses a deformable restrictor member <b>320</b>, an oscillation member <b>322</b> having a one-way valve <b>352</b>, a glide surface <b>326</b>, and an adjustment plate <b>354</b>. The OPEP device <b>300</b> also includes a mouthpiece <b>312</b>, a chamber inlet <b>314</b>, a chamber outlet <b>316</b>, and a respiratory portal <b>350</b>.

The OPEP device <b>300</b> is different from the OPEP device <b>200</b> in that it includes a biasing member comprised of at least one pair of magnets <b>362</b>. For each pair of the at least one pair of magnets <b>362</b>, one magnet is positioned on the oscillation member <b>322</b> and another magnet is positioned on the adjustment plate <b>354</b>. The magnets in each pair have opposing polarities. As such, the oscillation member <b>322</b> is biased by the at least one pair of magnets <b>362</b> into the engaged position with the deformable restrictor member <b>320</b>.

During the administration of OPEP therapy, the at least one pair of magnets <b>362</b> functions in the same manner as the coil spring, as discussed above. Specifically, as a user exhales into the OPEP device <b>300</b> and the deformable restrictor member <b>320</b> expands, the at least one pair of magnets <b>362</b> resist the movement of oscillation member <b>322</b>. After the deformable restrictor member <b>320</b> has reached its maximum point of expansion and quickly returned to its natural shape, the at least one pair of magnets <b>362</b> bias the oscillation member <b>322</b> from the disengaged position back to the engaged position. Furthermore, like the OPEP device <b>200</b>, the amount of bias supplied by the at least one pair of magnets <b>362</b> may be adjusted by rotating the at least one thumb screw <b>356</b>, thereby moving the adjustment plate <b>354</b> and the magnets positioned thereon closer to the magnets positioned on the oscillation member <b>322</b>.

The foregoing description of the inventions has been presented for purposes of illustration and description, and is not intended to be exhaustive or to limit the inventions to the precise forms disclosed. It will be apparent to those skilled in the art that the present inventions are susceptible of many variations and modifications coming within the scope of the following claims.